1. Home
  2. NEXA vs XNCR Comparison

NEXA vs XNCR Comparison

Compare NEXA & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$9.69

Market Cap

1.0B

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$14.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
XNCR
Founded
1956
1997
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
NEXA
XNCR
Price
$9.69
$14.07
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$6.20
$22.78
AVG Volume (30 Days)
715.4K
751.8K
Earning Date
02-19-2026
11-05-2025
Dividend Yield
1.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
$150,132,000.00
Revenue This Year
$4.43
$18.81
Revenue Next Year
$2.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
38.16
52 Week Low
$4.44
$6.92
52 Week High
$9.55
$24.66

Technical Indicators

Market Signals
Indicator
NEXA
XNCR
Relative Strength Index (RSI) 73.34 33.73
Support Level $8.72 $14.97
Resistance Level $9.25 $15.42
Average True Range (ATR) 0.41 0.69
MACD 0.03 -0.28
Stochastic Oscillator 95.11 1.59

Price Performance

Historical Comparison
NEXA
XNCR

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: